Hyperfine Stock Today
| HYPR Stock | USD 1.01 0.01 0.98% |
Performance0 of 100
| Odds Of DistressOver 52
|
Hyperfine is selling at 1.01 as of the 25th of November 2024; that is 0.98 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.96. Hyperfine has 52 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Hyperfine are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 27th of January 2021 | Category Healthcare | Classification Health Care |
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. The company was incorporated in 2014 and is based in Guilford, Connecticut. Hyperfine operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 57.89 M outstanding shares of which 1.56 M shares are currently shorted by private and institutional investors with about 33.29 trading days to cover. More on Hyperfine
Moving together with Hyperfine Stock
| 0.69 | AGL | agilon health Buyout Trend | PairCorr |
Moving against Hyperfine Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Hyperfine Stock Highlights
| President CEO | Maria Sainz | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsHyperfine can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Hyperfine's financial leverage. It provides some insight into what part of Hyperfine's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hyperfine (HYPR) is traded on NASDAQ Exchange in USA. It is located in 351 New Whitfield Street, Guilford, CT, United States, 06437 and employs 131 people. Hyperfine is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 74.41 M. Hyperfine conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 57.89 M outstanding shares of which 1.56 M shares are currently shorted by private and institutional investors with about 33.29 trading days to cover.
Hyperfine currently holds about 145.1 M in cash with (41.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.06, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Hyperfine Probability Of Bankruptcy
Ownership AllocationHyperfine has a total of 57.89 Million outstanding shares. Hyperfine retains 9.0 (percent) of its outstanding shares held by insiders and 24.35 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hyperfine Ownership Details
Hyperfine Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bridgeway Capital Management, Llc | 2024-09-30 | 142.7 K | |
| Northern Trust Corp | 2024-09-30 | 93.9 K | |
| Two Sigma Investments Llc | 2024-09-30 | 62.9 K | |
| Wealth Enhancement Advisory Services, Llc | 2024-09-30 | 49.9 K | |
| Signaturefd, Llc | 2024-09-30 | 49.1 K | |
| Procyon Private Wealth Partners, Llc | 2024-09-30 | 47.8 K | |
| Barclays Plc | 2024-06-30 | 45 K | |
| Lpl Financial Corp | 2024-09-30 | 39.7 K | |
| Ep Wealth Advisors, Inc. | 2024-09-30 | 34.7 K | |
| Vanguard Group Inc | 2024-09-30 | 3.2 M | |
| Fosun International Ltd | 2024-09-30 | 1.7 M |
Hyperfine Historical Income Statement
Hyperfine Stock Against Markets
Hyperfine Corporate Management
| Scott White | Chief Officer | Profile | |
| Neela Paykel | Gen Officer | Profile | |
| Alok Gupta | Chief Officer | Profile | |
| Thomas Teisseyre | Chief Officer | Profile | |
| Dave Castiglioni | Chief Officer | Profile |
Additional Tools for Hyperfine Stock Analysis
When running Hyperfine's price analysis, check to measure Hyperfine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hyperfine is operating at the current time. Most of Hyperfine's value examination focuses on studying past and present price action to predict the probability of Hyperfine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hyperfine's price. Additionally, you may evaluate how the addition of Hyperfine to your portfolios can decrease your overall portfolio volatility.